A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Baroda BNP Paribas Health and Wellness Fund - Direct Plan
Regular
Direct
1 Year Absolute Returns
-
NAV (₹) on 15 May 2026
10.11
1 Day NAV Change
0.41%
Risk Level
Very High Risk
Rating
-
Baroda BNP Paribas Health and Wellness Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Baroda BNP Paribas Asset Management India Limited.. Launched on 09 Jun 2025, ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
09 Jun 2025
Min. Lumpsum Amount
₹ 1,000
Fund Age
0 Yrs
AUM
₹ 530.21 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.73%
Scheme Type
Open Ended
Exit Load
1%
Asset Allocation
AUM
₹ 530.21 Cr
Equity
296.76%
Money Market & Cash
2.88%
Other Assets & Liabilities
0.94%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 69.43% |
| Hospitals & Medical Services | 17.89% |
| Finance - Life Insurance | 6.24% |
| Treps/Reverse Repo | 2.88% |
| IT Enabled Services | 1.56% |
| Medical Equipment & Accessories | 1.09% |
| Finance & Investments | 1.05% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 9.38% | ₹ 49.73 | Pharmaceuticals |
| Lupin Limited | 6.09% | ₹ 32.27 | Pharmaceuticals |
| IPCA Laboratories Limited | 5.34% | ₹ 28.32 | Pharmaceuticals |
| Abbott India Limited | 5.28% | ₹ 27.98 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 5.13% | ₹ 27.20 | Pharmaceuticals |
| Laurus Labs Limited | 4.78% | ₹ 25.32 | Pharmaceuticals |
| Fortis Healthcare Limited | 4.35% | ₹ 23.07 | Hospitals & Medical Services |
| Apollo Hospitals Enterprise Limited | 4.32% | ₹ 22.91 | Hospitals & Medical Services |
| JB Chemicals & Pharmaceuticals Limited | 4.24% | ₹ 22.48 | Pharmaceuticals |
| AstraZeneca Pharma India Limited | 4.03% | ₹ 21.35 | Pharmaceuticals |
| Emcure Pharmaceuticals Limited | 3.44% | ₹ 18.23 | Pharmaceuticals |
| SBI Life Insurance Company Limited | 3.43% | ₹ 18.19 | Finance - Life Insurance |
| Aster DM Healthcare Limited | 2.97% | ₹ 15.77 | Hospitals & Medical Services |
| Clearing Corporation of India Ltd | 2.88% | ₹ 15.29 | Others |
| ICICI Prudential Life Insurance Company Limited | 2.81% | ₹ 14.90 | Finance - Life Insurance |
| Glenmark Pharmaceuticals Limited | 2.72% | ₹ 14.44 | Pharmaceuticals |
| Aurobindo Pharma Limited | 2.62% | ₹ 13.89 | Pharmaceuticals |
| Dr. Lal Path Labs Limited | 2.58% | ₹ 13.67 | Hospitals & Medical Services |
| Gland Pharma Limited | 2.09% | ₹ 11.10 | Pharmaceuticals |
| Divi's Laboratories Limited | 2.07% | ₹ 10.99 | Pharmaceuticals |
| Ajanta Pharma Limited | 1.86% | ₹ 9.88 | Pharmaceuticals |
| Acutaas Chemicals Limited | 1.76% | ₹ 9.35 | Pharmaceuticals |
| MedPlus Health Services Limited | 1.64% | ₹ 8.72 | Pharmaceuticals |
| Inventurus Knowledge Solutions Limited | 1.56% | ₹ 8.27 | IT Enabled Services |
| Nephrocare Health Services Ltd | 1.50% | ₹ 7.94 | Hospitals & Medical Services |
| Concord Biotech Limited | 1.29% | ₹ 6.85 | Pharmaceuticals |
| Mankind Pharma Limited | 1.27% | ₹ 6.74 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 1.25% | ₹ 6.61 | Pharmaceuticals |
| Metropolis Healthcare Limited | 1.12% | ₹ 5.96 | Hospitals & Medical Services |
| Cipla Limited | 1.11% | ₹ 5.89 | Pharmaceuticals |
| Poly Medicure Limited | 1.09% | ₹ 5.76 | Medical Equipment & Accessories |
| Procter & Gamble Health Limited | 1.08% | ₹ 5.74 | Pharmaceuticals |
| Max Financial Services Limited | 1.05% | ₹ 5.55 | Finance & Investments |
| Jupiter Life Line Hospitals Limited | 1.04% | ₹ 5.52 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 0.96% | ₹ 5.10 | Pharmaceuticals |
| Rainbow Childrens Medicare Limited | 0.01% | ₹ 0.07 | Hospitals & Medical Services |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 2.44% | - | - | - |
| Category returns | 2.10% | 3.84% | 9.55% | 22.53% |
Fund Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does ... Read more
AMC Details
Name
Baroda BNP Paribas Asset Management India Limited.
Date of Incorporation
24 Nov 1994
CEO
Mr. Sanjay Kumar Grover
CIO
Mr. Sanjay Chawla
Type
Bank Sponsored
Address
501, Titanium, 5th Floor,
Western Express Highway,
Goregaon (E), Mumbai, Maharashtra, India - 400063
Website
http://www.barodapioneer.in
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata Housing Opportunities Fund
Sector
Regular
|
₹14.35 | -1.46% | 33.09% | 0.00% | ₹476 | 2.48% |
Very High
|
|
Tata Housing Opportunities Fund
Sector
Regular
|
₹14.35 | -1.46% | 33.09% | 0.00% | ₹476 | 2.48% |
Very High
|
|
Tata Housing Opportunities Fund
Sector
Regular
|
₹14.35 | -1.46% | 33.09% | 0.00% | ₹476 | 2.48% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Diversified
Direct
|
₹16.86 | -2.60% | 32.86% | 61.49% | ₹1,177 | 1.18% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Sector
Direct
|
₹16.86 | -2.60% | 32.86% | 61.49% | ₹1,177 | 1.18% |
Very High
|
|
HSBC Business Cycles Fund - Direct Plan
Diversified
Direct
|
₹26.43 | -7.72% | 32.63% | 63.79% | ₹1,149 | 1.39% |
Very High
|
|
HSBC Business Cycles Fund - Direct Plan
Diversified
Direct
|
₹26.43 | -7.72% | 32.63% | 63.79% | ₹1,149 | 1.39% |
Very High
|
|
Taurus Banking And Financial Services Fund - Direct Plan
Sector
Direct
|
₹57.36 | -2.60% | 32.20% | 77.20% | ₹11 | 1.68% |
Very High
|
|
Taurus Banking And Financial Services Fund - Direct Plan
Sector
Direct
|
₹58.03 | -2.60% | 32.19% | 77.24% | ₹11 | 1.68% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹16.09 | 3.05% | 31.73% | 0.00% | ₹4,370 | 1.34% |
Very High
|
Top Funds from Baroda BNP Paribas Asset Management India Limited.
FAQs
What is the current NAV of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth is ₹10.11 as of 15 May 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth is ₹530.21 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth?
Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth has delivered returns of 0.00% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth?
Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth?
The minimum lumpsum investment required for Baroda BNP Paribas Health and Wellness Fund - Direct Plan Growth is ₹1,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
AMFI April Data Highlights: Equity Inflows Dip 5% MoM, SIP Contributions Slow Down -
Best Mutual Funds in India: Top 5 Mid Cap Mutual Funds With More than 20% Returns in 5 Yrs -
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+